Jazz Pharma To FDA: What Patient Deaths?
Blaming your contracted distributor for failing to report serious adverse events, such as patient deaths, on a timely basis is probably not a sound strategy when offering explanations to the FDA. Consider Jazz Pharmaceuticals, which was tagged by the agency for failing to report at least 10 patient deaths, but insisted fault lay with its […]
Read More »Category : News
FDA Chemist Pleads Guilty To Insider Trading
Seven months after his scheme came to light, FDA chemist Cheng Yi Liang pleaded guilty today to charges that he used confidential information about upcoming announcements of 27 different FDA approval decisions involving 19 publicly traded companies and generated more than $3.6 million in illegal profits for himself. The 57-year-old Liang pleaded guilty to one […]
Read More »Category : News
Abbott To Split: Two Pharma Are Better Than One?
In a bid to unlock the perceived value in product line-up and geographic markets, Abbott Laboratories plans to separate into two publicly traded companies. The move is the latest gambit by a big drugmaker to reinvent itself on the premise that its growth potential is hampered by investors who have failed to appreciate a diverse […]
Read More »Category : News
FDA Warns About Risk of Eye Damage From Halloween Contact Lenses
Federal regulators are warning that Halloween contact lenses and other costume lenses may pose a risk of serious eye damage for the wearer if care isn’t paid in choosing the right ones. The FDA issued a consumer warning on October 12, reminding the public that contact lenses are medical devices that should be chosen with […]
Read More »Category : News
CooperVision, FDA step up public warning about recalled contact lenses
Nearly two months after problems were first announced, contact lens giant CooperVision Inc. and federal health regulators have amped up public warnings about nearly 780,000 recalled contact lenses, urging users to return the potentially defective products and to seek medical care if they show symptoms of harm. The federal Food and Drug Administration on Friday […]
Read More »Category : News
Lobbyists circle US drug makers over deficit talks
With pressure mounting for a deficit-reduction deal in Congress, the $300 billion U.S. pharmaceutical industry is looking a little like a ship at sea with danger in the water below. Drug makers have begun to emerge as a favorite target for cost-cutting proposals from others in the healthcare sphere who hope to avoid the fiscal […]
Read More »Category : News
Tech needed to cut rise of fake drugs on Twitter, research says
Spam filtering and identification is needed to stop Twitter becoming another platform for pushers of fake or substandard drugs, researchers say.
Read More »Category : News
KV Pharma Sues Former CEO Over $37M In Benefits
Now that Marc Hermelin, the former chairman and ceo at KV Pharmaceutical, has pleaded guilty to presiding over the production and distribution of oversized tablets (see here), the drugmaker has filed a lawsuit in hopes it can avoid having to pay nearly $37 million in retirement benefits, The St. Louis Post-Dispatch reports. The lawsuit, which […]
Read More »Category : News
A Military Doc Is Sentenced For Taking Goodies
Earlier this year, we wrote that US Army Major Jason Layne Davis, who was the chief cardiologist at Madigan Army Medical Center in Tacoma, Washington, was paid $4,812 by Boston Scientific’s Guidant unit in 2007 to ‘train’ two of the device maker’s sales reps. They watched as he implanted devices in patients, and between 2006 […]
Read More »Category : News
Occupy Pfizer? Protesters Target Job Cuts
The anti-Wall Street protests are, indeed, fanning out. And the latest permutation is about to target job cuts made by large corporations. As it so happens, Pfizer is high on the list. A group called Connecticut Working Families, which is a coalition of community groups, labor unions and activists, plans a vigil outside Pfizer facilities […]
Read More »Category : News
